imageCorporateStructure

1.This simplified corporate structure illustrates the key investments of the Group only. The equity percentage reflects the total direct shareholdings held by the Group, associates, joint ventures and funds managed by the Group as at 31 December 2021. The companies marked in the solid line boxes are consolidated investments of the Group, and the companies marked in the dotted-line boxes are non-consolidated investments of the Group. The companies marked in the shaded boxes are channels for C-end top priority of the Group.

2.The companies marked in the light blue boxes are invested by Fosun Pharma. For specific information, please refer to the disclosure of Fosun Pharma. The company marked in the light brown box is invested by Sanyuan Foods. For specific information, please refer to the disclosure of Sanyuan Foods.

3.The companies marked in the light yellow boxes are invested by Yuyuan. For specific information, please refer to the disclosure of Yuyuan. The companies marked in the light orange boxes are invested by FTG. For specific information, please refer to the disclosure of FTG.

4.The companies marked in the light green boxes are invested by Nanjing Iron & Steel. For specific information, please refer to the disclosure of Nanjing Iron & Steel. The company marked in the light purple box is invested by Hainan Mining. For specific information, please refer to the disclosure of Hainan Mining.

5.The Company and Fidelidade held 49% and 50.85% equity interest in Luz Saúde, respectively. Therefore, the Group held 92.22% effective equity interest in Luz Saúde.

6.Shanghai Zhuli holds “Fosun Care” brand. The Group through its wholly-owned subsidiaries and a consolidated fund under its management held 87.35% and 3.55% equity interest, respectively, in Shanghai Zhuli. The Group held 39.99% effective equity interest in such fund. Therefore, the Group held 88.78% effective equity interest in Shanghai Zhuli.

7.The Group through its wholly-owned subsidiary and a consolidated fund under management of the Group held 16.67% and 3.78% equity interest, respectively, in Sanyuan Foods. The Group held 37.30% effective equity interest in such fund. Therefore, the Group held 18.08% effective equity interest in Sanyuan Foods.

8.The Company and its wholly-owned subsidiary held 29.77% equity interest in BabyTree, and Fidelidade held 0.14% equity interest therein. Therefore, the effective equity interest held by the Group in BabyTree was 29.88%.

9.Yuyuan held 38% equity interest in Jinhui Liquor; therefore, the Group held 26.02% effective equity interest in Jinhui Liquor.

10.Yuyuan held 70% equity interest in its joint venture, Sichuan Tuopai Shede Group Co., Ltd., which held 30.32% equity interest in Shede Spirits.

11.The Group through its subsidiaries 28.97% equity interest in Bohe Health, and Yuyuan through its wholly-owned subsidiary held 0.88% equity interest in Bohe Health. Therefore, the Group held 28.71% effective equity interest in Bohe Health.

12.St Hubert SAS was held 98.12% by an associate of the Group.

13.Shanghai Zhiying Equity Investment Management Co.,Ltd. holds “Fosun RZ Capital” brand.

14.In March 2022, the Group acquired 50% equity interest in BFC. As at the date of this announcement, the Group held 100% equity interest in BFC.

15.The Group held 58.92% equity interest in Nanjing Iron & Steel through Nanjing Nangang, a joint venture of the Group.

16.The Group held 49% equity interest in ROC through a wholly-owned subsidiary and Hainan Mining held 51% equity interest in ROC. Therefore, the Group held 73.92% effective equity interest in ROC.

17.The Group held 59.07% equity interest in Easun Technology through its wholly-owned subsidiaries and consolidated funds under its management. Therefore, the Group held 48.42% effective equity interest in Easun Technology. In addition, the non-consolidated entites in which the Group participated in the investment held 24.63% equity interested in Easun Technology.

18.The Group through its wholly-owned subsidiary and a consolidated fund under management of the Group held 18.11% and 2.35% equity interest, respectively, in JEVE. The Group held 22.14% effective equity interest in such fund. Therefore, the Group held 18.63% effective equity interest in JEVE. In addition, the non-consolidated fund managed by the Group held 23.92% equity interest in JEVE.